id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-344011-w9zn7hb2	Schiffrin, Ernesto L	Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?	2020-05-16		.txt	text/plain	670	45	59	Hajra and Bandyopadhyay have cited recent retrospective studies 6,7 that were published after our Editorial in the last month that support our conclusion that there is no evidence of harm of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with COVID-19. As well, among a total of 18,472 patients tested for COVID-19 in the Cleveland Clinic Health System in Ohio and Florida between March 8 and April 12, 2020, there was no association of use of ACEIs and ARBs with testing positive A c c e p t e d M a n u s c r i p t 3 for COVID-19, 9 which suggests that taking these agents did not increase susceptibility to infection by the novel virus RAS-CoV-2. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China	./cache/cord-344011-w9zn7hb2.txt	./txt/cord-344011-w9zn7hb2.txt